These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32515234)
1. A dynamic model of the opioid drug epidemic with implications for policy. Homer J; Wakeland W Am J Drug Alcohol Abuse; 2021 Jan; 47(1):5-15. PubMed ID: 32515234 [No Abstract] [Full Text] [Related]
2. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372 [TBL] [Abstract][Full Text] [Related]
3. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732 [TBL] [Abstract][Full Text] [Related]
4. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement. Zang X; Skinner A; Krieger MS; Behrends CN; Park JN; Green TC; Walley AY; Morgan JR; Linas BP; Yedinak JL; Schackman BR; Marshall BDL JAMA Netw Open; 2024 May; 7(5):e2413861. PubMed ID: 38814644 [TBL] [Abstract][Full Text] [Related]
6. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study. Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561 [TBL] [Abstract][Full Text] [Related]
7. Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis. Taylor M; Pradhan A; Ogando YM; Shaya F Am J Drug Alcohol Abuse; 2022 May; 48(3):338-346. PubMed ID: 35467459 [No Abstract] [Full Text] [Related]
8. Legal requirements and recommendations to prescribe naloxone. Haffajee RL; Cherney S; Smart R Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248 [TBL] [Abstract][Full Text] [Related]
9. Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties. Cerdá M; Hamilton AD; Hyder A; Rutherford C; Bobashev G; Epstein JM; Hatna E; Krawczyk N; El-Bassel N; Feaster DJ; Keyes KM Epidemiology; 2024 May; 35(3):418-429. PubMed ID: 38372618 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process. Smart R; Grant S Int J Drug Policy; 2021 Dec; 98():103383. PubMed ID: 34340167 [TBL] [Abstract][Full Text] [Related]
12. Opioid education and nasal naloxone rescue kits in the emergency department. Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910 [TBL] [Abstract][Full Text] [Related]
13. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015. Rowe C; Wheeler E; Stephen Jones T; Yeh C; Coffin PO J Urban Health; 2019 Feb; 96(1):6-11. PubMed ID: 29725887 [TBL] [Abstract][Full Text] [Related]
14. Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy-Observational study. Takeda MY; Katzman JG; Dole E; Bennett MH; Alchbli A; Duhigg D; Yonas H Subst Abus; 2016; 37(4):591-596. PubMed ID: 27093555 [TBL] [Abstract][Full Text] [Related]
15. The changing landscape of naloxone availability in the United States, 2011 - 2017. Freeman PR; Hankosky ER; Lofwall MR; Talbert JC Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192 [TBL] [Abstract][Full Text] [Related]
16. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply. Bell A; Bennett AS; Jones TS; Doe-Simkins M; Williams LD Subst Abus; 2019; 40(1):52-55. PubMed ID: 29558283 [No Abstract] [Full Text] [Related]
17. The Role of Emergency Medical Services in the Opioid Epidemic. Joiner A; Kumar L; Barhorst B; Braithwaite S; Prehosp Emerg Care; 2021; 25(4):462-464. PubMed ID: 32795103 [TBL] [Abstract][Full Text] [Related]
18. "A Blessing and a Curse:" Opioid Users' Perspectives on Naloxone and the Epidemic of Opioid Overdose. Kline A; Mattern D; Cooperman N; Dooley-Budsock P; Williams JM; Borys S Subst Use Misuse; 2020; 55(8):1280-1287. PubMed ID: 32182153 [No Abstract] [Full Text] [Related]
19. Lessons learned from ramping up a Canadian Take Home Naloxone programme during a public health emergency: a mixed-methods study. Young S; Williams S; Otterstatter M; Lee J; Buxton J BMJ Open; 2019 Oct; 9(10):e030046. PubMed ID: 31662368 [TBL] [Abstract][Full Text] [Related]
20. Naloxone Administration Frequency During Emergency Medical Service Events - United States, 2012-2016. Cash RE; Kinsman J; Crowe RP; Rivard MK; Faul M; Panchal AR MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(31):850-853. PubMed ID: 30091966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]